Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays

Int J Tuberc Lung Dis. 2020 Dec 1;24(12):1307-1311. doi: 10.5588/ijtld.20.0396.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antitubercular* / pharmacology
  • Antibiotics, Antitubercular* / therapeutic use
  • Drug Resistance, Bacterial
  • Humans
  • Mycobacterium tuberculosis* / genetics
  • Rifampin / pharmacology
  • Sensitivity and Specificity

Substances

  • Antibiotics, Antitubercular
  • Rifampin